Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) traded up 1.7% on Monday . The stock traded as high as $21.61 and last traded at $21.61. 2,268 shares changed hands during trading, a decline of 99% from the average session volume of 155,954 shares. The stock had previously closed at $21.25.
Analyst Ratings Changes
Separately, Truist Financial increased their price target on Guardian Pharmacy Services from $24.00 to $25.00 and gave the stock a "buy" rating in a report on Friday.
Get Our Latest Stock Analysis on Guardian Pharmacy Services
Guardian Pharmacy Services Stock Up 4.8 %
The company has a 50 day moving average of $20.43 and a 200 day moving average of $20.64.
Institutional Trading of Guardian Pharmacy Services
A number of large investors have recently made changes to their positions in GRDN. GAMMA Investing LLC acquired a new position in shares of Guardian Pharmacy Services in the 1st quarter valued at $170,000. R Squared Ltd acquired a new stake in Guardian Pharmacy Services in the fourth quarter valued at $30,000. Investment Research & Advisory Group Inc. purchased a new stake in shares of Guardian Pharmacy Services in the fourth quarter valued at about $34,000. BNP Paribas Financial Markets acquired a new stake in Guardian Pharmacy Services during the 4th quarter valued at $37,000. Finally, Compass Financial Services Inc acquired a new position in shares of Guardian Pharmacy Services in the fourth quarter valued at approximately $58,000.
Guardian Pharmacy Services Company Profile
(
Get Free Report)
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Featured Articles
Before you consider Guardian Pharmacy Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.
While Guardian Pharmacy Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
